IAMA Therapeutics is a clinical-stage pharmaceutical company focused on developing innovative therapies for neurodevelopmental and cognitive disorders, particularly drug-resistant epilepsy, through selective NKCC1 inhibition
IAMA Therapeutics is a clinical-stage pharmaceutical company focused on developing innovative therapies for neurodevelopmental and cognitive disorders, particularly drug-resistant epilepsy, through selective NKCC1 inhibition.